Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks for sharing this bigfoot9460. Interesting.
GLTU/A.
True. I was expecting an 8-K, but not this one. There's always next week.
GLTU/A.
Neither. Just informational. There's an item specifically in the 8-K for these types of securities sales.
https://media2.mofo.com/documents/faq-form-8-k.pdf
You did realize that right?
GLTU/A.
I'd like to see CYDY close at $2.30, COB.
Would set the next leg up very nicely with some news.
TGIF all, our time is neigh.
GLTU/A.
This is good intel. When did NP join the company? Not as acting CEO but actually join the company (as it seems you have the details at your reach)?
Thanks.
GLTU/A.
There were figures thrown around this board and other boards in the tune of anywhere from $1250-$1500 per from estimates off of previous webcasts. I just took a extremely conservative number of $250. Lets just say it's $1000 to use as a round number, minus the discount (20% is last I heard from Dr. Nicholas) + Chiral's cut, IMHO would still get us above $250 easily. We won't know until an 8-K or the 10-Q, whichever comes first.
GLTU/A.
Anyone else sense that 8-K coming? What would CYDY consider material? Maybe if the full allotment to PH was filled? Even if it was filled for only $250/vial (which is an EXTREMELY and STUPIDLY conservative number), that takes care of toxic debt still with some cash at hand.
The smarter shorts are covering daily. For all others outstanding: as Tom Cruise would say.. 'that's Risky Business'.
GLTU/A.
JLAIns - exactly. Thought it was real clear for anyone trying to get in at a good price.. So, for the sake of a low SP, Fife toxic debt is diminishing away and we just signed the first of many PO orders from APAC while in the meantime we have 2 Brazil trials with extremely good setup for 700mgs and 4 doses by the Sponsor (A. Einstein hospital) AND the readout shortly with LongHaulers with a molecule that can cross the BBB???
*edit - WAIT I FORGOT ABOUT MacLeod in INDIA!
5 for 1, anyone??
ALL IMHO.
GLTU/A.
Did you account for the previous month in terms of total aggregate sale? Also according to your math, he should be done by mid June, if what you're stating is correct. It's cumulative sales, not point in time. Again if what you're saying is correct.
Looking to load up 1 last time so thanks for the info.
GLTU/A.
There's an industry average that takes 10-15 years to bring a drug to fruition. According to my math you have 1 year left and on target.
Keep on, keeping on. We're close.
Save/help lives and make money. IMHO, that's the true American Dream.
GLTU/A.
IMO - there were bits of info on the Long Hauler trial (last patient) and also HIV BLA. Cash cow and money in the bank, respectively that I did not know of.
Well worth the PA video.
GLTU/A.
One thing I'd like to clear up for people regarding the 200K vials per country. After speaking to the company, they have not limited 200K to each country. They committed the entire inventory subject to approval.
Food for thought as we are 1 step closer to being a MULTI-billion dollar company. All, IMO.
GLTU/A.
MC - can you please relay to the offering group they may need to up the ante? This stock will get pricey real fast, especially after LH read-out and any wildcard like PH EUA or India news. Thanks and welcome back! Always appreciate your posts..
GLTU/A.
Grip - straight from the horses mouth:
"Agreements with each of the distributors will be attached to our 10K filed by July 29, 2021, which will specify this information if it hasn’t already been disclosed."
No need to keep asking here. Wait for official company word (like the rest of us).
GLTU/A.
THINGS JUST GOT REAL HERE IN CYDYLAND.
Going to be VERY VERY VERY INTERESTING JUNE. HANG ON TIGHT.
THIS DAMN SHIP HAS SAILED. BON VOYAGE...
GLTU/A.
Boru FD- "it's frustrating, but I'm in it for longhaul," I'm right here with you. Past month had a ton of shakeout. Would imagine only hardcore longs are in this now, whether with a deep in the money SP or the opposite. One things for sure, this company is at the precipice of something tantamount in the next few months. Glad to have you along for the ride (along with the others).
GLTU/A.
Didn't NP say on a call CYDY would be transparent as possible with shareholders? While I would always prefer the past tense version of the 'todo' verbs, isn't he just being 'transparent'?
I would suggest for the next call that many submit questions regarding the future tensing of the PR's and them only send out past tense.
BIG Picture - we're moving along with the Brazil trials, lets keep our focus hitting SS with Critical and Severe. Our sponsor AEH doesn't seem to be ones to mess around..
GLTU/A.
Vyera wouldn't have been my first choice (for HIV) but are you discounting the fact that they did partner with Biomm and Macleod? For a pre-rev biotech, you need to compare apples to apples in terms of partnership, no?
GLTU/A.
Whether there is a plan or not, it seems the percentage is more 5.6%. At least according to synthesis:1's analysis.
https://drive.google.com/file/d/1bVxLOsHTrTJRtcjnNj1PE59NoQRaoOBb/view
Interesting read, though his focus is too much on a prolific poster.
Just sharing info.
I am neither pro/con the plan.
I just want to see the LH readout and Interim Brazil at 120 for Critical.
GLTU/A.
Damn well put C-20. With all the 'craziness' with this company, it's still moving forward, inch by inch. Nothing, not even a pandemic will stop this moving train. We'll get there. Soon.
GLTU/A.
You're assuming that the ones that made it over the 50% vote hadn't accumulated more. You know what happens with assumptions right? Last I saw of the 13D there were quite some purchases (as well as sales). It will be interesting this time around, what gets voted on, etc.
GLTU/A.
Thanks for the links. It will make for a better case. Will try to send this to the 45 trial hospital sites to add to the new moderate trial CYDY is doing in Brazil. Hopefully this can stave off the pneumonias. Maybe add it to SOC?
GLTU/A.
"Zpak can cure pneumonia at home without IV." - link please?
"LMAO"? As long as one isn't laughing themselves to sleep, it's always good to laugh.
GLTU/A.
Yep (didn't have time to read through the NCT on clinical). thanks for clarifying!
GLTU/A.
Mels, Thanks for clarifying..
GLTU/A.
IMHO, it really looks like 3rd times the charm for LL and Covid (CD10,12 and now CD16). IV's? All 700mgs? To top it off, against Placebo (not even SOC)?? If this isn't garauteed with all we know about LL's MOA, I really don't know what is. No wonder mgmt decided to take the p hit for an interim look at 120. I'm VERY please with Biomm and our partner hospitals at Beth Israel. Great addition, IMO, with C. Recknor.
Not for nothing but NP and the BOD may just bring us across the finish line. A little late but across nontheless. July optimistic?? Maybe. Brazil and Argentina still hit hard and it's not letting up anytime soon..
GLTU/A.
Was waiting for this. And extremely happy as an investor that it's 4 doses AS IT WAS SUPPOSED TO BE for CD12. Thanks for posting this. Made my day.
GLTU/A.
"As before...no big rush to vote right now. We'll see how things play out." -- sometimes staying quiet speaks volumes..
Looking forward to start of the Brazil trial and the LH read-out (in June).
GLTU/A.
This is a great link, thanks for sharing.
GLTU/A.
Ok, fair about REM. I've posted a lot of links previously. Lets flip it and have you back the fact that it wasn't sold? Fair?
GLTU/A.
Who said they weren't?
I know the WHO said they weren't allowing Rem. Fact (google it).
GLTU/A.
Can only fool the world for so long:
"When the plasma therapy was dropped as a cure to COVID-19 earlier this week, Dr. DS Rana, Chairperson- Ganga Ram Hospital had said that Remdesivir was being considered to be dropped from the ‘line of treatment’, even though it has become one of the most crucial weapons to fight against the Coronavirus; only because there is no reliable evidence of its efficacy and positive impact on a patient."
Looks like Gilead's Rem's time is up.
https://goachronicle.com/who-drops-remdesivir-from-official-list-of-covid-19-treatments/amp/?__twitter_impression=true
Open's up a nice gaping hole for a traatment that actually takes people off ecmo.. Is it Leronlimab's time to shine?
Lets find out very soon.
GLTU/A.
"I'm literally laughing myself to sleep" - never even realized that was possible until you posted it. Looks like the mountain can be moved on this board. Nice.
GLTU/A.
BLULLISH - thanks for the look, I am checking this.
GLTU/A.
I hope that was the phone call that turned the drop to a wave to a tsunami for CYDY. Thanks for leading the charge Dr. Misiu143.
I don't doubt for a second they won't call both other Dr's..
GLTU/A.
WOW -- talk about being active. Nice stuff misiu143!
Lets keep on keeping on!
PLEASE let us know how it goes, if it can be made public.
GLTU/A.
"Like asking ones mother if they are good looking." -- little voice- that actually made me LOL. Nice one.
Good to see a fellow CYDY shareholder with wit.
GLTU/A.
Grip - "And I know NOBODY leaves a company when you’re “THIS CLOSE” to revenue and foreign EUA." -- now this is something I can get behind..
Nice.
GLTU/A.
"Mulholland took himself out as CFO, he is staying with the company as senior Vice President, that’s not an exit to me. He decided to lighten his load but stay with the company, he hasn’t jumped ship or abandoned the company, I don’t get the fanatical hype at all." -- apparently this is what happens when one skims the 8-K. Sometimes it makes sense to double read things online, right?
GLTU/A.
Enjoy: https://emerginggrowth.com/cytodyn-cydy-conference-call-roundup/
"This topline data clearly shows the drop off in benefit on day 21 from not dosing with the drug. This 14 day data is new and has not yet been studied and may meet that EUA test of “may be effective.” So the shorts betting on no EUA in the United States may yet be in for a surprise. There is a lot of publicity surrounding leronlimab that prompted the FDA statement, so the data will be analyzed by the FDA. Independent doctors like Dr Lalezari have taken to the airwaves lobbying for an EUA for critical COVID-19 patients. This interview is excellent as Dr. Lalezari explains why the FDA needs more data and explains the rationale behind the new dosing regimen and how it was a factor in the success of the upcoming trials. "
OH MY.
GLTU/A.